UBE2I and pancreatic adenocarcinoma: Consistently, our experiments showed increased promoter hypermethylation of UBE2I in PAAD tumors relative to control, which retained significance upon stratification by gender, race, and nodal metastasis, supporting the involvement of UBE2I hypermethylation in the development of PAAD.